Cite
HARVARD Citation
Tanaka, E. et al. (2015). Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study. Modern rheumatology. 25 (4), pp. 503-513. [Online].